LETI Pharma
LETI Pharma is a privately-held Spanish pharmaceutical company founded in 1919 that develops and distributes medical skincare (LETI AT4, LETI SR, LETI balm) and allergen-specific immunotherapies through German pharmacies and online platforms for patients with atopic dermatitis, rosacea, dry skin, and allergies.
- Company typePrivate
- Founded1919
- HeadquartersMadrid, Spain
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What LETI Pharma does
LETI Pharma, S.L.U. is a privately-held Spanish pharmaceutical company headquartered in Spain and founded in 1919 by a doctor and a pharmacist, focused on the intersection of dermatology and immunology. The company develops, manufactures, and distributes prescription-adjacent medical skincare and allergen-specific immunotherapies, targeting patients with atopic dermatitis (neurodermitis), sensitive or reddened skin including rosacea subtype I, very dry or compromised skin, and allergies such as pollen or house dust mite. The company celebrated its 100th anniversary in 2019 and operates as a family-owned business with continuous research activity since founding.
The product portfolio is organized into three dermatology lines — LETI AT4 (atopic-prone skin, addressing the four symptoms of dryness, itching, irritation, and superinfection risk, formulated with prebiotics such as alpha-glucan oligosaccharide, bisabolol, and barrier-repair ingredients), LETI SR (vascular protection line for rosacea and couperose using probiotic Lactobacillus Ferment), and LETI balm (intensive barrier repair with ceramides and 20% urea foot care) — alongside Hyposensibilisierung allergen-specific immunotherapy (SIT) offerings for causal allergy treatment. LETI AT4 has been clinically tested in over 50 studies, with reported user-survey outcomes including a 92% recommendation rate and 56% reduction in itching among children with neurodermitis.
The business model rests on B2B sales to the German pharmacy channel under AGB agreements, supported by an external sales force and pre-printed order forms; a separate Fachkreise (professional healthcare) channel — gated by DocCheck authentication — supplies physicians with diagnostic tools and customized SIT preparations ordered through a proprietary online portal (vacunas.leti.com) and delivered directly to practices. Distribution is executed by Health Logistics in Bruchsal, and products are additionally listed across at least nine German online pharmacy marketplaces (Shop Apotheke, DocMorris, Medpex, Aponeo, Apotal, Volksversand, Medikamente-per-Klick, MyCare, Apodiscounter). Revenue is generated from one-time product sales across all three segments (skincare, immunotherapy preparations, and diagnostic products), with no subscription or licensing pricing model disclosed. Pricing is not publicly disclosed and varies by pharmacy retail channel.
LETI Pharma firmographics
Firmographics- Name
- LETI Pharma
- Legal name
- LETI Pharma, S.L.U.
- Website
- https://leti.de
- Company type
- Private
- Founded year
- 1919
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- LETI Pharma is a privately-held Spanish pharmaceutical company founded in 1919 that develops and distributes medical skincare (LETI AT4, LETI SR, LETI balm) and allergen-specific immunotherapies through German pharmacies and online platforms for patients with atopic dermatitis, rosacea, dry skin, and allergies.
- Ownership category
- akta.pro rank
LETI Pharma industry classification
Industry- Product category
- Dermatological Pharmaceuticals
- NAICS
- Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (42421)
- SIC
- Perfumes, Cosmetics & Other Toilet Preparations (2844), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK)
- akta.pro secondary industries
- Dermocosmetics & Medical-Grade Skincare (CRABAAAF), Sensitive Skin & Barrier Repair (CRABAAAG), Dermatology Specialty Pharmaceuticals (HLAIACAL), Dermatology OTC & Skin Health (Acne Treatments, Eczema/Psoriasis OTC, Antifungals, Wart Removal) (CRADAMAF)
Keywords
Where LETI Pharma is headquartered
LocationHeadquarters
- HQ city
- Madrid
- HQ country
- Spain
- HQ region
- Europe
Offices2 records
Markets served
LETI Pharma business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales
Revenue model
- Medical Skincare Products: Sale of medical skincare products (LETI AT4, LETI SR, LETI balm lines) to pharmacies and end consumers through pharmacy channel.
- Specific Immunotherapy (SIT): Customized allergen immunotherapy preparations for allergy treatment, ordered through physicians and delivered to practices or pharmacies.
- Diagnostic Products: Sale of diagnostic tools for healthcare professionals in the Fachkreise (professional) segment.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
LETI Pharma product offering
Product offeringCore offering
LETI Pharma researches, develops, manufactures, and sells medical skincare products under three sub-brands — LETI AT4 (atopic-prone skin), LETI SR (sensitive/reddened skin and rosacea subtype I), and LETI balm (very dry and rough skin) — and provides allergen-specific immunotherapy (hyposensibilisierung) preparations for the causal treatment of pollen, house dust mite, and other allergies. Products are distributed primarily through pharmacies and physician practices across Germany and Western Europe, with a dedicated professional (Fachkreise) channel supplying diagnostic tools and customized immunotherapy to dermatologists and allergists.
Product overview
LETI Pharma is a Spanish pharmaceutical company founded in 1919 specializing in allergy treatments and medical skin care. The company operates three core product lines: (1) LETI AT4 - a comprehensive skin care range specifically formulated for dry, atopic-prone skin (atopic dermatitis/neurodermitis), addressing four key symptoms: skin dryness, itching, irritation, and tendency toward superinfections; (2) LETI SR - products for sensitive and reddened skin, couperose, and rosacea subtype I, offering double vascular protection; and (3) LETI balm - intensive care for very dry and rough skin with products for body, feet, lips, and nasal areas. Additionally, LETI Pharma offers allergen-specific immunotherapy (hyposensibilisierung) as a causal allergy treatment. Products are distributed through pharmacies and specialized online pharmacy platforms in Germany.
Differentiator
Problem solved
Functional benefit
Brands
- LETI AT4: Dermatological skincare line specifically developed for dry skin prone to atopic dermatitis (neurodermatitis). The AT stands for 'Atopic' and the 4 represents the effectiveness against the 4 typical symptoms of atopic dermatitis: skin dryness, itching, skin irritations, and tendency to superinfections.
- LETI SR
- LETI balm
Products and services
- LETI AT4 Medical skincare line for dry skin prone to atopic dermatitis (neurodermitis). Addresses the four typical symptoms — skin dryness, itching, skin irritations, and tendency toward superinfections — by repairing the skin barrier and restoring microbiome balance using prebiotic alpha-glucan oligosaccharide, bisabolol, and skin-barrier repair ingredients. Range includes shower/bath gel, intensive cream, body lotion, facial cream, and eye lid gel. Indicated for babies from 3 months, children, and adults.
- LETI SR Medical skincare line for sensitive and reddened skin, including couperose and rosacea subtype I. Provides dual vascular protection that stabilizes capillary walls and strengthens supporting connective tissue, using probiotic Lactobacillus Ferment. Range includes micellar cleansing water, anti-redness serum, mineral SPF 30 facial cream, and an on-the-go anti-redness facial spray. Clinically tested to reduce redness and support skin recovery after facial laser treatments.
- LETI balm Medical skincare line for very dry, rough, or stressed skin on the body, feet, lips, and peribucal area. Ceramide-based formulations and 20% urea foot care repair the skin barrier, relieve itching and tension, and provide intensive moisture. Range includes 20% urea foot care cream, peribucal protective balm, rich body balsam, and a natural nasal/lip fluid. Indicated for babies from 6 months, children, and adults depending on the SKU.
- Allergen-Specific Immunotherapy (Hyposensibilisierung) Customized allergen-specific immunotherapy (hyposensibilisierung) preparations offered as a causal treatment for many allergies, enabling sustainable freedom from symptoms. Indicated for pollen allergy, house dust mite allergy, and other allergens. Prescriptions are placed by physicians through LETI's online ordering portal with order tracking, and the customized preparations are delivered to practices or pharmacies for patient administration.
Quantifiable outcome
- 92% of users recommend LETI AT4 products (n=871, user survey trnd/TERRITORY GmbH, 01/2022)
- +5 more outcomes
Companies that use LETI Pharma
Customer profileSegments5 records
Ideal customer profiles3 records
LETI Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
LETI Pharma partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Health LogisticscoreHealth Logistics serves as the contracted distribution partner for delivering products to German pharmacies. Located at Vichystr. 14, 76646 Bruchsal, Germany. Handles logistics and shipping of all goods to pharmacy customers.
Scale indicators1 record
Recent moves6 records
Expansion highlights5 records
LETI Pharma competitors and assessment
Company assessmentBroad incumbents
- CeraVe (L'Oréal): Mass-market ceramide-based skincare brand with strong presence in sensitive/dry-skin and atopic-prone categories. Competes with LETI AT4 and LETI balm in consumer mindshare and pharmacy distribution.
- Eucerin (Beiersdorf): Beiersdorf's medical skincare brand for dry skin, atopic dermatitis, and sensitive skin, sold through German pharmacies. Sells adjacent product categories with much larger marketing spend and global reach.
- Avène (Pierre Fabre): French dermo-cosmetic brand for sensitive and reactive skin, including redness/rosacea products that overlap with LETI SR. Distributed through European pharmacies.
- Bioderma (NAOS): French dermatological skincare brand with Atoderm range for atopic and very dry skin, distributed in European pharmacies. Overlaps with LETI AT4 and LETI balm in the dry/barrier-repair category.
- La Roche-Posay (L'Oréal): L'Oréal-owned dermatologist-recommended skincare brand with Lipikar range for atopic-prone skin. Overlaps with LETI AT4 in atopic dermatitis and sensitive skin categories globally.
Direct peers
- Dr. Wolff Group (Alpecin / Linola / Vagisan): German mid-sized pharma company with dermatology and consumer health product lines (Linola for dry/eczema-prone skin) sold through German pharmacies. Closely comparable family-owned niche German dermo-pharma peer.
- Stallergenes Greer: Global leader in allergen immunotherapy (SIT/sublingual) for pollen, mite, and other allergies. Directly comparable to LETI in the immunotherapy franchise, and a much larger incumbent in the same therapeutic category.
- HAL Allergy: European allergen immunotherapy specialist with both diagnostic and therapeutic SIT products. Directly competes with LETI's immunotherapy and diagnostic offerings across DACH markets.
- ALK-Abelló: Danish-headquartered global allergen immunotherapy company with subcutaneous and sublingual products. Directly comparable to LETI's SIT/hyposensibilization franchise; competing in German-speaking Europe as well.
- Wörwag Pharma: Mid-sized German pharmaceutical company specializing in dermatology, neurology, and immunology products distributed via German pharmacies. Strong comparable as a German mid-market dermo/allergy pharma peer.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
LETI Pharma social profiles
Digital presenceLETI Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
LETI Pharma leadership team
Management profileNumber of profiles
LETI Pharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
LETI Pharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about LETI Pharma
What does LETI Pharma do?
LETI Pharma researches, develops, manufactures, and sells medical skincare products under three sub-brands — LETI AT4 (atopic-prone skin), LETI SR (sensitive/reddened skin and rosacea subtype I), and LETI balm (very dry and rough skin) — and provides allergen-specific immunotherapy (hyposensibilisierung) preparations for the causal treatment of pollen, house dust mite, and other allergies. Products are distributed primarily through pharmacies and physician practices across Germany and Western Europe, with a dedicated professional (Fachkreise) channel supplying diagnostic tools and customized immunotherapy to dermatologists and allergists.
Is LETI Pharma a public or private company?
LETI Pharma is a private company. It is classified as family owned and is currently operating.
When was LETI Pharma founded?
LETI Pharma was founded in 1919. It employs 101 to 250 people.
Where is LETI Pharma based?
LETI Pharma is headquartered in Madrid, Spain, in the Europe region.
How does LETI Pharma make money?
Three revenue lines are on record. Medical Skincare Products are the primary driver. The others are specific Immunotherapy (SIT) and diagnostic Products.
Who are LETI Pharma's main competitors?
Broad incumbents on record are CeraVe (L'Oréal), Eucerin (Beiersdorf), Avène (Pierre Fabre), Bioderma (NAOS) and La Roche-Posay (L'Oréal). Direct peers are Dr. Wolff Group (Alpecin / Linola / Vagisan), Stallergenes Greer, HAL Allergy, ALK-Abelló and Wörwag Pharma.
Does LETI Pharma have an API?
No public API is recorded for LETI Pharma.
What industry is LETI Pharma in?
LETI Pharma's product category is Dermatological Pharmaceuticals. Its primary akta.pro industry code is HLAIAAAK, Dermatology & Aesthetics Pharmaceuticals, with a secondary code of CRABAAAF, Dermocosmetics & Medical-Grade Skincare. Its NAICS code is 3254 and its SIC code is 2844.